SEE ALSO...
Items 11 to 20 of 22 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
GYKI 53655 hydrochloride | 143692-48-2 | sc-361203 sc-361203A | 10 mg 50 mg | $228.00 $966.00 | ||
GYKI 53655 hydrochloride is a selective antagonist of glutamate receptors, characterized by its ability to modulate receptor conformations through specific binding interactions. This compound exhibits unique steric properties that influence the receptor's ion permeability, leading to altered synaptic transmission. Its rapid kinetics allow for transient effects on neuronal excitability, while its solubility in physiological conditions supports effective engagement with target sites, contributing to its distinct regulatory profile in excitatory neurotransmission. | ||||||
ZK 200775 | 161605-73-8 | sc-204421 sc-204421A | 10 mg 50 mg | $189.00 $796.00 | ||
ZK 200775 is a potent modulator of glutamate receptors, distinguished by its ability to stabilize specific receptor states through unique hydrogen bonding interactions. This compound exhibits a remarkable affinity for allosteric sites, influencing receptor dynamics and ion channel activity. Its kinetic profile reveals a fast onset of action, allowing for precise temporal control over synaptic signaling. Additionally, ZK 200775's solubility enhances its accessibility to neuronal membranes, facilitating effective receptor engagement. | ||||||
CFM-2 | 178616-26-7 | sc-203429 | 10 mg | $207.00 | ||
CFM-2 is a selective modulator of glutamate receptors, characterized by its unique ability to engage in specific hydrophobic interactions that alter receptor conformation. This compound demonstrates a distinct binding affinity for the orthosteric site, impacting ion permeability and neurotransmitter release. Its reaction kinetics indicate a gradual onset, allowing for sustained modulation of synaptic transmission. Furthermore, CFM-2's lipophilicity enhances its membrane permeability, promoting effective receptor interaction. | ||||||
GYKI 47261 dihydrochloride | 1217049-32-5 | sc-203993 sc-203993A | 10 mg 50 mg | $185.00 $781.00 | ||
GYKI 47261 dihydrochloride is a potent antagonist of glutamate receptors, exhibiting a unique mechanism of action through competitive inhibition at the receptor site. Its structural features facilitate strong electrostatic interactions, which stabilize the binding complex and influence receptor dynamics. The compound's rapid kinetics allow for swift modulation of receptor activity, while its solubility profile enhances its distribution in biological systems, promoting effective engagement with target receptors. | ||||||
3-MATIDA | 518357-51-2 | sc-203470 sc-203470A | 10 mg 25 mg | $577.00 $1103.00 | ||
3-MATIDA functions as a selective modulator of glutamate receptors, characterized by its ability to induce conformational changes in receptor subunits. This compound engages in specific hydrogen bonding interactions that enhance receptor affinity, leading to altered signaling pathways. Its unique steric configuration allows for distinct allosteric modulation, influencing downstream neuronal excitability. Additionally, 3-MATIDA exhibits favorable lipophilicity, facilitating membrane permeability and receptor accessibility. | ||||||
UBP 282 | 544697-47-4 | sc-203715 sc-203715A | 10 mg 50 mg | $175.00 $739.00 | ||
UBP 282 acts as a potent allosteric modulator of glutamate receptors, distinguished by its unique ability to stabilize receptor conformations. This compound engages in specific hydrophobic interactions that fine-tune receptor activity, impacting synaptic transmission dynamics. Its selective binding profile promotes distinct signaling cascades, enhancing or inhibiting neurotransmitter release. Furthermore, UBP 282's molecular rigidity contributes to its kinetic stability, allowing for sustained receptor engagement. | ||||||
UBP 301 | 569371-10-4 | sc-203716 sc-203716A | 10 mg 50 mg | $388.00 $1533.00 | ||
UBP 301 functions as a selective modulator of glutamate receptors, characterized by its unique capacity to alter receptor dynamics through specific electrostatic interactions. This compound exhibits a distinct binding affinity that influences ion channel permeability, thereby affecting neuronal excitability. Its structural flexibility allows for rapid conformational changes, facilitating diverse signaling pathways. Additionally, UBP 301's interaction with lipid membranes enhances its bioavailability, promoting effective receptor engagement. | ||||||
1-Naphthylacetyl Spermine | 122306-11-0 | sc-206189 | 25 mg | $390.00 | 1 | |
1-Naphthylacetyl Spermine acts as a potent modulator of glutamate receptors, distinguished by its ability to stabilize receptor conformations through hydrophobic interactions. This compound exhibits a unique kinetic profile, influencing the rate of receptor activation and desensitization. Its aromatic structure allows for π-π stacking with adjacent residues, enhancing binding specificity. Furthermore, its solubility properties facilitate effective membrane penetration, optimizing receptor interaction dynamics. | ||||||
5,7-Dichlorokynurenic acid | 131123-76-7 | sc-200440 sc-200440A | 10 mg 50 mg | $74.00 $409.00 | ||
5,7-Dichlorokynurenic acid is a selective antagonist of glutamate receptors, characterized by its ability to disrupt excitatory neurotransmission. Its unique chlorinated structure enhances binding affinity through electrostatic interactions with receptor sites. This compound exhibits distinct allosteric modulation, influencing receptor dynamics and signaling pathways. Additionally, its solubility in biological membranes allows for effective localization and interaction with target proteins, impacting synaptic plasticity. | ||||||
YM 90K hydrochloride | 154164-30-4 | sc-361415 sc-361415A | 5 mg 25 mg | $189.00 $829.00 | ||
YM 90K hydrochloride is a potent modulator of glutamate receptors, distinguished by its unique ability to selectively inhibit receptor activation. Its structural conformation facilitates specific hydrogen bonding and hydrophobic interactions, enhancing its binding efficacy. The compound exhibits rapid kinetics in receptor engagement, leading to significant alterations in synaptic signaling. Furthermore, its stability in aqueous environments allows for prolonged activity, influencing neuronal excitability and synaptic transmission. | ||||||